7 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... Antifungal Treatment ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... 6 months to 1 year ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... screen within 1 year ... HumanPapillomavirus #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... for Preventing ... Cryptococcosis #Cryptococcus ... #IDSA #Prevention ... #Treatment #management
Syphilis - Clinical Manifestations and Treatment

1) Primary Syphilis
 • Direct lesion contact during sex is responsible
Neurological: Headache, meningitis ... ulcerated • MSK ... Early latent year ... Late latent >1 year ... stages #diagnosis #management
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
IDSA Recommendations ... Late-Latent (>1 year ... Treponema #pallidum #IDSA ... #Prevention #Treatment ... #management #opportunistic